Neogen Shares Outstanding 2010-2025 | NEOG

Neogen shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Neogen Annual Shares Outstanding
(Millions of Shares)
2024 216
2023 189
2022 108
2021 107
2020 106
2019 105
2018 104
2017 102
2016 101
2015 100
2014 99
2013 97
2012 96
2011 95
2010 92
2009 90
Neogen Quarterly Shares Outstanding
(Millions of Shares)
2025-02-28 217
2024-11-30 217
2024-08-31 217
2024-05-31 216
2024-02-29 217
2023-11-30 216
2023-08-31 217
2023-05-31 189
2023-02-28 216
2022-11-30 216
2022-08-31 108
2022-05-31 108
2022-02-28 108
2021-11-30 108
2021-08-31 108
2021-05-31 107
2021-02-28 107
2020-11-30 107
2020-08-31 107
2020-05-31 106
2020-02-29 106
2019-11-30 106
2019-08-31 105
2019-05-31 105
2019-02-28 105
2018-11-30 105
2018-08-31 106
2018-05-31 104
2018-02-28 104
2017-11-30 104
2017-08-31 103
2017-05-31 102
2017-02-28 103
2016-11-30 102
2016-08-31 102
2016-05-31 101
2016-02-29 101
2015-11-30 101
2015-08-31 101
2015-05-31 100
2015-02-28 100
2014-11-30 100
2014-08-31 99
2014-05-31 99
2014-02-28 99
2013-11-30 100
2013-08-31 99
2013-05-31 97
2013-02-28 98
2012-11-30 97
2012-08-31 97
2012-05-31 96
2012-02-29 96
2011-11-30 96
2011-08-31 96
2011-05-31 95
2011-02-28 96
2010-11-30 95
2010-08-31 94
2010-05-31 92
2010-02-28 93
2009-11-30 92
2009-08-31 92
2009-05-31 90
2009-02-28 91
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.302B $0.924B
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.634B 27.97
Boston Scientific (BSX) United States $152.531B 38.19
Stryker (SYK) United States $145.427B 30.41
EssilorLuxottica (ESLOY) France $127.535B 0.00
Medtronic (MDT) Ireland $109.709B 15.55
Haleon (HLN) United Kingdom $49.754B 28.33
Lonza Group Ag (LZAGY) Switzerland $49.468B 0.00
ResMed (RMD) United States $36.224B 27.21
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Agilent Technologies (A) United States $32.148B 20.88
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.748B 89.29
Koninklijke Philips (PHG) Netherlands $21.431B 15.40
Zimmer Biomet Holdings (ZBH) United States $18.172B 11.67
Baxter (BAX) United States $15.441B 11.53
Smith & Nephew SNATS (SNN) United Kingdom $12.754B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.002B 20.89
Lantheus Holdings (LNTH) United States $5.375B 13.56
Prestige Consumer Healthcare (PBH) United States $4.194B 18.74
Perrigo (PRGO) Ireland $3.646B 9.24
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.213B 23.69
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.048B 14.09
LeMaitre Vascular (LMAT) United States $1.872B 41.85
AtriCure (ATRC) United States $1.719B 0.00
Acuren (TIC) United States $1.300B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.110B 24.97
BioLife Solutions (BLFS) United States $1.016B 0.00
Kestra Medical Technologies (KMTS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.986B 12.60
InMode (INMD) Israel $0.930B 9.37
Evolus (EOLS) United States $0.642B 0.00
CeriBell (CBLL) United States $0.612B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Curaleaf Holdings (CURLF) Canada $0.544B 0.00
Valneva SE (VALN) France $0.519B 0.00
Owens & Minor (OMI) United States $0.517B 4.29
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Surmodics (SRDX) United States $0.422B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.336B 0.00
VAREX IMAGING (VREX) United States $0.326B 11.98
Aurora Cannabis (ACB) Canada $0.302B 53.70
Cresco Labs (CRLBF) United States $0.277B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.63
Sanara MedTech (SMTI) United States $0.259B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanuwave Health (SNWV) United States $0.242B 0.00
Canopy Growth (CGC) Canada $0.222B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Verano Holdings (VRNOF) United States $0.216B 0.00
Quanterix (QTRX) United States $0.211B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Biote (BTMD) United States $0.194B 5.46
Brainsway (BWAY) Israel $0.192B 50.95
High Tide (HITI) Canada $0.185B 0.00
Omeros (OMER) United States $0.184B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.81
Organigram Global (OGI) Canada $0.178B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.135B 16.58
Jin Medical (ZJYL) China $0.122B 0.00
TerrAscend (TSNDF) Canada $0.098B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Veru (VERU) United States $0.090B 0.00
Fonar (FONR) United States $0.090B 11.62
Agape ATP (ATPC) $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
InterCure (INCR) Israel $0.070B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.048B 0.00
United-Guardian (UG) United States $0.037B 12.94
Nephros (NEPH) United States $0.035B 46.71
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00